2022 Health Alerts
NDHAN Update on COVID-19 therapeutics (8/8/2022)
NDHAN Monkeypox Management in Certain Patient Populations
NDHAN: Health Advisory Human Parechovirus (PeV) Infections in Neonates and Young Infants
NDHAN: Health Advisory Syphilis on the Rise
NDHAN: Monkeypox Update for Providers
NDHAN: COVID-19 Rebound after Paxlovid treatment
NDHAN: Monkeypox in the United States and Other Countries
NDHAN Update: Guidance for Adenovirus Testing and Typing of Patients Under Investigation - Pediatric Acute Hepatitis of Unknown Etiology
NDHAN Detection of HPAI H5N1 in Colorado Patient
NDHAN: Health Advisory Call for Case Reports - Pediatric Acute Hepatitis of Unknown Etiology
NDHAN: Testing, treatment and infection control recommendations for providers managing patients with confirmed or suspected avian influenza
NDHAN: Health Advisory Update to COVID-19 laboratory reporting requirements to public health: Effective April 4, 2022.
NDHAN: Health Advisory Update on Evusheld
NDHAN: Health Advisory Abbott Recalls Infant Formulas Concerning Infections with Cronobacter sp. and Salmonella sp.
NDHAN: Health Advisory HSS UPdate on COVID-19 therapeutics
NDHAN: Health Advisory FDA Approves First Injectable Treatment for Pre-Exposure Prophylaxis (PrEP)
NDHAN: Health Advisory Update: Omicron Variant Update
Download alert (pdf)
Download COVID-19 Outpatient Therapeutics Decision Guide (pdf)
NDHAN: Health Advisory Update: Omicron and COVID-19 Therapies